ID

34272

Description

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets; ODM derived from: https://clinicaltrials.gov/show/NCT01510522

Lien

https://clinicaltrials.gov/show/NCT01510522

Mots-clés

  1. 16/01/2019 16/01/2019 -
  2. 14/05/2019 14/05/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

16 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus Type 2 NCT01510522

Eligibility Diabetes Mellitus Type 2 NCT01510522

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
Description

ID.1

Type de données

boolean

on treatment with metformin tablets
Description

ID.2

Type de données

boolean

patients with at least 2 treated co-morbidities
Description

ID.3

Type de données

boolean

established dose of metformin > 1.700 mg/day
Description

ID.4

Type de données

boolean

age > 18 years old
Description

ID.5

Type de données

boolean

given informed consent
Description

ID.6

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients not able to take medication orally
Description

ID.7

Type de données

boolean

according to summary of product characteristics (smpc)
Description

ID.8

Type de données

boolean

participating in another clinical trial 30 days prior to randomization
Description

ID.9

Type de données

boolean

any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
Description

ID.10

Type de données

boolean

Similar models

Eligibility Diabetes Mellitus Type 2 NCT01510522

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
boolean
ID.2
Item
on treatment with metformin tablets
boolean
ID.3
Item
patients with at least 2 treated co-morbidities
boolean
ID.4
Item
established dose of metformin > 1.700 mg/day
boolean
ID.5
Item
age > 18 years old
boolean
ID.6
Item
given informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
patients not able to take medication orally
boolean
ID.8
Item
according to summary of product characteristics (smpc)
boolean
ID.9
Item
participating in another clinical trial 30 days prior to randomization
boolean
ID.10
Item
any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial